Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
-
19681
-
19682
Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling
Published 2017“…Fluoxetine inhibited both Wnt3A- and LiCl-induced loss of proteoglycans in chondrogenically differentiated ATDC5 cells. …”
-
19683
Overview of selected datasets.
Published 2025“…In this study, we analyzed publicly available 16S amplicon sequencing datasets from four geographical locations using a single workflow.</p><p>Methods</p><p>We employed Quantitative Insights Into Microbial Ecology v.2 for microbial diversity analysis and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States v.2 for functional pathway predictions of the gut microbiota in patients with PTB and antitubercular therapy.…”
-
19684
Ribosomal S6 phosphorylation in whole brain homogenate.
Published 2022“…<p><b>A)</b> Representative western blot images from surgically resected brain tissue of Active participants after taking 4.5 mg/m<sup>2</sup> everolimus for 7 days and controls. …”
-
19685
Frailty and quality of life among older people with and without a cancer diagnosis: Findings from TOPICS-MDS
Published 2017“…A ten percent increase in frailty was also associated with a decrease in QOL at baseline (CSAL:-0.35 (95%-CI:-0.38;-0.32), EQ-5D:-0.12 (95%-CI:-0.12;-0.11)) and follow-up (CSAL:-0.27 (95%-CI:-0.30;-0.24), EQ-5D:-0.07 (95%-CI:-0.07;-0.06)). …”
-
19686
-
19687
-
19688
-
19689
-
19690
-
19691
-
19692
-
19693
-
19694
-
19695
-
19696
-
19697
-
19698
-
19699
-
19700